QLAIRA cpr pell 3 x 28 pce
7680588580021
CH-58858
G03AB08
09.02.1.
1 / 3
google
Details
- Product number
- 5885801
- CPT
- -
- Packaging group
- 3 x 28
- Unit
- Dragée(s)
- Composition
- I) dunkelgelbe Tablette: estradioli valeras 3.000 mg, lactosum monohydricum 48.360 mg, maydis amylum, amylum pregelificatum, povidonum K 25, magnesii stearas, hypromellosum, macrogolum 6000, talcum, E 171, E 172 (flavum), pro compresso obducto. II) mittelrote Tablette: estradioli valeras 2.000 mg, dienogestum 2.000 mg, lactosum monohydricum 47.360 mg, maydis amylum, amylum pregelificatum, povidonum K 25, magnesii stearas, hypromellosum, macrogolum 6000, talcum, E 171, E 172 (rubrum), pro compresso obducto. III) hellgelbe Tablette: estradioli valeras 2.000 mg, dienogestum 3.000 mg, lactosum monohydricum 46.360 mg, maydis amylum, amylum pregelificatum, povidonum K 25, magnesii stearas, hypromellosum, macrogolum 6000, talcum, E 171, E 172 (flavum), pro compresso obducto. IV) dunkelrote Tablette: estradioli valeras 1.000 mg, lactosum monohydricum 50.360 mg, maydis amylum, amylum pregelificatum, povidonum K 25, magnesii stearas, hypromellosum, macrogolum 6000, talcum, E 171, E 172 (rubrum), pro compresso obducto. V) weisse Placebotablette: lactosum monohydricum 52.1455 mg, maydis amylum, povidonum K 25, magnesii stearas, hypromellosum, talcum, E 171, pro compresso obducto.
Articles (1)
Qlaira, Filmtabletten
Filmtabletten
3 x 28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
IV
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
III
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
I
|
3.0 MG | Substance | Wirkstoff (Principe actif) |
|
V
|
52.1455 MG | Substance | HBESI |
|
V
|
- | Substance | HNIDK |
|
III
|
3.0 MG | Substance | Wirkstoff (Principe actif) |
|
IV
|
50.36 MG | Substance | HBESI |
|
I
|
48.36 MG | Substance | HBESI |
|
II
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
IV
|
- | Substance | HNIDK |
|
III
|
46.36 MG | Substance | HBESI |
|
V
|
- | Substance | HNIDK |
|
II
|
47.36 MG | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
V
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
V
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
V
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
V
|
- | Substance | FNIDK |
|
II
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
I
|
- | Substance | FNIDK |
|
IV
|
- | Substance | FNIDK |
|
II
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
II
|
- | Substance | FNIDK |
|
I
|
- | Substance | FTODK |
|
IV
|
- | Substance | FTODK |
|
III
|
- | Substance | FNIDK |
|
III
|
- | Substance | FTODK |
|
II
|
- | Substance | FTODK |
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 58858
- Drug name
- Qlaira, Filmtabletten
- Galenic form
- FILM
- ATC Code
- G03AB08
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 17/09/2009
- Authorization expiration date
- 31/12/9999
- IT number
- 09.02.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- QLAIRA cpr pell 3 x 28 pce
- Description (DE)
- QLAIRA Filmtabl 3 x 28 Stk
- Market launch
- 17/09/2009
- Narcotic (BTM)
- No